Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:31 PM
Ignite Modification Date:
2025-12-24 @ 10:31 PM
NCT ID:
NCT02810535
Eligibility Criteria:
Inclusion Criteria:
* Informed consent
* Seasonal or all-season symptoms of an allergic or non-allergic rhinitis
* Healthy non-allergic subjects
Exclusion Criteria:
* Patients: Age \<18 and \> 45
* Other severe diseases (e.g. Cystic fibrosis, diseases with immunosuppression, malignant diseases)
* Previously occurred allergic shock
* Pregnancy and lactation
* Participation in another clinical trial within the last 30 days
* Inability to measure the length and the consequences of the study
* Frequent use of medication which could not be discontinued in the defined time before enrollment: nasal vasoconstrictors 1 day; antihistamines 3 days; nasal steroids 7 days; oral cortison 4 weeks; leukotriene antagonists and cromolyn 2 days before NPT
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
45 Years
Study:
NCT02810535
Study Brief:
Protocol Section:
NCT02810535